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Antagonism of normal enteric flora has been considered for some time  as a 
possible factor in resistance to enteric diseases. 
Nissle (1) first reported that stool cultures from typhoid carriers became negative 
for Salmonella after  oral administration  of viable Escherichia coli to  the  patients. 
Gratia (2) subsequently described an in vitro antagonism between col[forms and there 
have been numerous later publications on colicines  and other antibiotic substances 
produced  by certain  bacteria  which  inhibit  the  growth  of other  bacterial  strains, 
species  and  genera.  Halbert  (3)  attempted  to  correlate  the  number  of antibiotic- 
producing  bacteria  in  the  intestine  of  human  beings  with  resistance  to  bacterial 
dysentery, but he interpreted the evidence obtained as largely inconclusive. 
More recently, another line of evidence for a possible protective effect of normal 
enteric flora was presented by Freter (4, 5) who found that fasting and oral adminis- 
tration  of streptomycin rendered  guinea pigs susceptible to enteric infection with a 
drug-resistant  strain  of  Vibrio cholerae. At about  the  same  time Bohnhoff, Drake, 
and  Miller  (6)  reported  that  the  susceptibility  of mice to  oral infection with  Sal- 
menella enteritidis was enhanced up to 100,000-fold  after the animals had received a 
large oral dose of streptomycin. While  these results  suggest an antagonistic action 
on the part of normal flora, there are two alternative explanations: (a) streptomycin 
might directly affect the intestinal tract in such a way as to predispose it to the action 
of enteric pathogens,  or  (b)  the  drug  might directly increase  the  virulence  of the 
bacteria studied. If these interpretations were correct, the reduction of normal enteric 
flora by streptomycin would  be  merely incidental;  i.e.  not directly related  to  the 
observed increase in susceptibility. 
The action of immune antibody has also been implicated  as a  protective  mech- 
anism  against  enteric  infection,  especially after  the  discovery by Davies  (7)  that 
antibody could be found in the intestinal lumen.  Burrows and his coworkers (8,  9) 
studied  this phenomenon in great detail  and  suggested the  term  coproantibody to 
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denote fecal antibody. The  study of  the  effect  of  immunization on resistance to 
enteric diseases  has  been hampered by the lack of experimental animals in which 
essential features of the human infections--such  as an abundant growth of the path- 
ogens in the  intestine---could be easily reproduced.  Studies on human volunteers 
and field studies have been carried out repeatedly (10,  11) but did not always yield 
very consistent and encouraging results. The question whether protective immunity 
to enteric diseases  actually does exist is  therefore far from being settled. 
The  present  paper  reports  (a)  a  method,  based  on  inhibition of  normal 
flora, which permits long term, non-fatal enteric infections of mice and guinea 
pigs with Shigella flexneri and Vibrio cholerae,  (b) direct evidence for the anti- 
bacterial action of antagonistic enteric flora, and (c)  the lack of antibacterial 
effect of active and oral passive immunization in such infections. The accom- 
panying publication (12)  will describe the protective  influence of  these  fac- 
tors on the outcome of the short term, fatal cholera infection in guinea pigs. 
Materials and Methods 
All animals were infected with  a  streptomycin-resistant  strain of Shigdla  flexneri  type 
2a or  Vibrio cholera* by its introduction  directly into the stomach. The resistant  Shigdla 
mutant was selected by the gradient plate technique from a  strain isolated in 1954. The 
Vibrio strain was the same as used in previous studies (4, 5). After some preliminary experi- 
ments the  following schedules were adopted. 
Infection of mice with Shigdla flexnerl.--The animals used were Swiss mice of 25 to 30 gm. 
weight. Two days before infection, 1 rag. erythromycin and 5 rag. streptomycin in 1 ml. 
water were given by stomach tube. No food was given on this day. Boiled tap water con- 
talning 0.1  mg.  erythromycin,  4  mg.  streptomycin,  and 400 units nystatin (mycostatin, 
Squibb)  per  ml.  were supplied ad  libitum  throughout  the  entire experiment.  Fox  chow 
(Rockland) was given during the day before infection but withdrawn at night. On the day 
of infection, a known number of viable Shigella organisms from a 24 hour agar culture was 
fed by stomach tube. The bacteria were suspended in 1 ml. veal infusion broth (Difco) con- 
raining 5 rag. streptomycin and 50 rag. CaCO3. In experiments requiring oral administration 
of antiserum  this was given 2  hours  before infection together  with  25 rag. CaCOa. The 
amount of CaCO3 given with the bacteria was then reduced to 25 rag. Beginning with the 
1st day after infection, fox chow (Rockland) was supplied ad libitum throughout the experi- 
ment. For assay of the infection, one stool pellet was collected from each mouse into 1 ml. 
sterile saline, emulsified, and streaked  not later than 3 hours  after  collection on desoxy- 
cholate agar  (Difco) containing 1 mg./ml, streptomycin.  Preliminary  experiments showed 
all bacteria  growing out on the plates  to be Shigdla.  However, confirmatory spot  checks 
by slide agglutination were made in all experiments as a matter of routine. A rough quanti- 
tafion of the number of Skigdla organisms excreted was achieved in the following way. All 
plates in which the first streak with one loopful of fecal suspension resulted in solid bacterial 
growth were interpreted  to indicate several million viable cells per milliliter of the original 
suspension. When the first streak  of fecal suspension gave isolated colonies the result was 
reported as "few Shigella organisms per fecal pellet."  Infected mice showed no gross symp- 
toms of disease. 
Infection of Guinea Pigs with Shigdla flex'neri or Vibrio cholerae.--Animals of the "Wright 
strain" (Abrams Small Stock Breeders, Chicago), weighing 350 to 400 gin. were treated  as 
follows. Two days before infection, 100 mg. streptomycin and 10 mg. erythrumycin were ROLI~ FRETER  413 
given by stomach tube in 10 ml. distilled  water.  No food was given on this  day.  Boiled  tap 
water containing  4 rag.  streptomycin,  0.I mg. erythromycin, and 400 units  nystatin  was 
supplied  ad Hbitum throughout the entire  experiment.  Rockland guinea pig food was given 
on the day before  infection  but  withdrawn at  night.  On the day of  infection,  750 mg. CaCO3 
suspended in 10 ml. water was fed by stomach tube.  Three hours later  a known number of 
viable  S/dgd/~ or Vibr/o  organisms from a 24  hour  agar  culture  were  given  by the  same route. 
The bacteria  were suspended in 15 ml.  veal  infusion  broth (Difco)  containing  50 rag.  strepto- 
mycin and 250 nag.  CaCO3. In experiments requiring  oral  administration  of normal or im- 
mune serum this  was given with the first  dose of CaCO3. Beginning with the Ist day after 
infection,  Rockland guinea pig food  was supplied ad lib~um  throughout  the experiment. 
With this method of infection,  death due to enteric cholera occurred  only rarely in guinea 
pigs of the size used. No death due to infection  with Shigella was observed.  The infection 
was therefore assayed by performing bacterial counts on fecal  specimen  in the following 
way. The animals were placed in individual cages which had a wire mesh bottom suspended 
over a  sterilized pan. After 2 hours, 10 fecal pellets were collected from the droppings and 
emulsified in 10 ml. sterile saline. The number of viable organisms  in  this suspension was 
determined by surface  plate count  on  desoxycholate  agar  (Difco)  containing  1  mg./ml. 
streptomycin. Only Shigella or  Vibrio were  recovered  from the feces of infected animals. 
However,  spot checks by slide agglutination were made as routine. 
Anti~sra  and  Active  Immunization.--Ail  antisera  employed  for  passive immunization 
were prepared in rabbits with the strain of Shigella or Vibrio that was used later for the 
challenge infections. For the preparation of antigens, the growth from 24 hour agar cultures 
was suspended  in saline and heated for 10 minutes at 56°C. without previous washing.  Six 
to eight intravenous injections of increasing amounts of antigen (0.2 rag. to 10 nag. dry weight) 
were given at 5 day intervals. The rabbits were bled on the 7th day after the last injection. 
All antisera were stored at --20°C. without preservative. 
Active immunization of mice was carried out by the intraperitoneal route with the strain 
of Shigdla .flexneri that was used for the subsequent  challenge infections. 
The streptomycin-resistant mutant of Escher~hia coli (25 rs) used in the present studies 
was selected by the gradient plate technique from a sensitive  strain isolated in 1954 from 
an  apparently healthy human  being. 
EXPERI~NTAL 
Bacterial  A ntagonism.--It  was  found  in  preliminary experiments  that  the 
enteric infections produced in mice and  guinea pigs with  the  techniques  de- 
scribed above were made possible by the action of streptomycin. No Shigella 
or  Vibrio  organisms could be recovered from the feces of orally infected ani- 
mals  which  had  not  been  treated  with  this  drug.  This  was  true  even  with 
inocula of several million viable organisms. Nystatin and erythromycin were 
given  to  prevent  superinfections  with  enterococci  and  yeast-like fungi.  The 
Shigella  or Vibrio infections thus produced were found to persist for the entire 
duration of an experiment (about 2 weeks). Little or no decrease in the number 
of organisms excreted occurred during that period.  In some  experiments the 
50 per cent infective dose was below 1000 organisms indicating a true infection; 
i.e. rapid and apparently unlimited multiplication of the bacteria in the host. 
As mentioned  above,  the  observed  increase  in  susceptibility of  mice  and 
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not in itself constitute conclusive proof for a  protective action of normal en- 
teric  flora,  because  certain  alternative  explanations  could  also  account  for 
these results. This problem was investigated in the following way. 
Six groups of 4 mice each were infected by stomach tube with mixtures of Sh. ~'n~ri and 
the streptomycin resistant strain of E. coli (25 rs). All animals received the same number 
(I0 X  10  6) of Shigella organisms and varying amounts of E. coli ranging from 10 X  lO  s to 
1 X 10  9 organisms. 
On the  1st day after infection stools from 19 of the 24 mice studied were 
positive for ShigeIla. On the 3rd day after infection Shigella could be recovered 
from only 4 out of 24 stool samples  1 while 17 cultures showed only abundant 
growth of E. coli (3 stool samples were sterile). A control group of 8 mice which 
had  received only Shigdla  organisms  gave  positive  stool  cultures  on  all  3 
days. On later days, all 24 mice excreted only E. coli while the 8 control mice 
continued  to  give stool  cultures  with  abundant  growth  of Shigella.  Similar 
experiments in  guinea  pigs  infected with Shigella flexr~ri  or  Vibrio  chol~ae 
showed identical results. 
These findings indicate a  strong antagonistic action on the part of the coli 
strain,  thus providing conclusive evidence for an in  vivo  protective effect of 
a common intestinal bacterium. 
The coli  strain used in the above experiments was  tested for in vitro  pro- 
duction of antibiotic substances which might be effective against the Shigdla 
or Vibrio strains studied. The test was carried out using the method described 
by Fredericq (13): 
A  macrocolony of the coli strain, about 10 ram. in diameter was grown for 48 hours at 
37°C. in the center of a veal infusion agar plate (veal infusion broth~ Difco~ with 1.5 per cent 
bacto agar and containing 1 reg./rot, streptomycin). The growth was then killed with chloro- 
form vapor and the plate reseeded with the Shigella  or  Vibrio  strain respectively. 
No zone of inhibition was noticed in either case. The same negative result 
was  obtained  with  a  similar  method  described  by  Halbert  (14),  involving 
simultaneous growth of the suspected colicine producer with  the  test strain. 
Proteose No. 3  agar (Difco) with and without addition of streptomycin was 
used in these tests. 
Active  and Passive Immunization.--The  following studies were carried out 
to detect any possible antibacterial effect of active and passive immunization 
in experimental enteric infections. 
Table I gives the results of an experiment in which the duration and severity 
of Shigella infection in normal and actively immunized mice were compared. 
The immunized mice had received 4  intraperitoneal injections of one-quarter LD60  dose 
of Shigella  flexneri antigen, given at  I0 day intervals. Infection was on the  7th day after 
1 All 4 samples were from mice in the group which bad received the second smallest dose 
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the last antigen injection.  The fractions in parenthesis in Table I  refer only to those mice 
which  excreted  a  large number  (at least several million)  of Shigdla  organisms  per pellet 
while the other fractions refer to all mice with positive stool cultures,  regardless of number 
of organisms recovered. 
No consistent or significant difference was found in the excretion of Shigella 
flexneri  by immunized mice as compared to  the normal control group  (Table 
I). At the end of this experiment (2 weeks) 5  mice each from the immunized 
and normal groups were bled and the agglutinin titers of their sera were deter- 
TABLE I 







Group No.*  4  5 
Infective dose in no. of shigella organisms 









3/4~  (3/4)§ 
6/6  (6/6) 
4/4  (1/4) 
6/6  (6/6) 
4/4  (3/4) 
6/6  (2/6) 
2/4  (1/4) 
6/6  (5/6) 
3/5  (3/5) 
4/5  (4/5) 
5/5  (2/5) 
4/5  (4/5) 
3/5  (0/5) 
5/s  (4/5) 
4/5  (4/5) 
4/5  (3/5) 
Total of groups 
1 to5 
15/26  (15/26) 
26/29  (26/29) 
22/25  (9/25) 
20/29  (16/29) 
21/25  (9/25) 
20/29  (7/29) 
19/25  (14/25) 
27/29  (19/29) 
* Individual data on groups 1 to 3 (infected with ii X  10e; I.I X  I0  e and ii0,000 organ- 
isms respectively) are omitted from the table. 
3/4, the stools from 3 out of 4 mice were positive for Shigella. 
§ (3/4), 3 out of 4 mice gave stool specimens from which large numbers of Shigella were 
recovered. 
mined.  Titers  ranged  between  1:250  and  1:1000  in  the  immunized  group 
while the sera from normal mice were negative in a  dilution of 1 : 4. 
Similar  experiments  were  carried  out  with  Vibrio  cholerae  and  Shigella 
flexneri  in guinea pigs which had been passively immunized with a  single dose 
of 2 ml. homologous antiserum given intragastrically 3 hours prior to infection. 
Control animals received 2 ml. normal rabbit serum instead of antiserum. Table II shows 
the results obtained in 2 representative experiments of this type, in which the animals had 
been infected with 1.5 X  I06 viable cells of Shigdlaflex'ncri or 10 X  106 viable cells of Vibrio 
cholerae respectively. 
As  can  be  seen,  passive  immunization  had  no  demonstrable  antibacterial 
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animals  (group D)  on the first day after  infection was  statistically  not  sig- 
nificant.---Other experiments with passively immunized mice and guinea pigs 
showed  similar  results.  The  mean  numbers  of  shigella  or  vibrio  recovered 
from the  immunized animals on the first or subsequent  days after infection 
were always insignificantly higher or lower than those of the controls.  Com- 
plement given orally together with the antiserum also had no effect. 
Burrows and Havens (15)  reported that antibody to  Vibrio choleras  admin- 
istered orally to  guinea pigs was not inactivated  to any large  degree in  the 
intestine.  These authors  could  recover 25  per cent  of the  original  oral  dose 
in the feces, collected over a  period of 1 week,  and  demonstrated that addi- 
tional  amounts  of antibody had  diffused  into  the  blood  stream.  As  will  be 
TABLE II 
Mean No. of Sh. flexneri or V. cholerae per Fecal Pellet* Recovered.from Normal and Passively 











Infected with Sh. fl~neri  Infected withV. ¢l~olerae 
Group A  Group B  Group C  Group D 
Normal serum  Antiserum~ter 
1:25600 
14  X  10  e 
8 
61  X  106 
7 
5  X  106 
7 
63  X  10  e 
5 
Normal serum 
ii  X  lO  s 
lO 
14  X  10  6 
II 




5.5  ×  10  e 
11 
36  ×  106 
11 
14  X  106 
11 
n--no, of animals tested. 
* Determined from a sample of 10 fecal pellets. 
described  later  (12),  the  method  of oral passive immunization  employed in 
the  present  experiments protected  guinea  pigs  against  death  from the  fatal 
enteric  cholera  infection.  Consequently,  excessive destruction  of antibody in 
the  intestinal  tract  cannot  account  for  the  lack  of  antibacterial  protection 
observed in the present studies. 
Another possible objection to the above experiments may be that the rapid 
growth of the enteric pathogens in the intestine,  which was possible because 
of the lack of inhibitory normal flora, may have masked any slight antibac- 
terial  effect of the  antibody.  The following experiment was designed  to  test 
this hypothesis. 
Three groups of 7 mice each (A, B, and C) were infected in the usual way with 1 X  10  s 
cells of ShigeUa flexneri. Two of these groups (B and C) received an additional 1 X  10  ° cells 
of E. coU 25 rs. One of the two latter groups (C) received 0.5 ml. antiserum to the Skigdla 
strain  (agglutinin tlter 1:12500) orally, while the other mice (groups A and B) were given gOT.F  r~.~x~R  417 
normal rabbit serum instead. Stool specimens were cultured on subsequent days. Table III 
illustrates  the  results  of  this  experiment. 
There was no observable effect of oral passive immunization on the 1st day 
after infection  (Table III).  It  seems  resonable  to  expect that  any  antibac- 
TABLE  III 




1st day after infection 
2nd and 3rd day after 
infection.. 
Sh. flexnerl, normal 
serum 
OnlyShigella in 4 out 
of  7  stool  speci- 
mens* 
OnlyShigella in 7 out 
of 7 specimens 
Sh. flexneri plus E. 
coli, normal serum 
90-99 per cent coli 1- 
10 per cent ShigeUa 
in 5 out of 7 stool 
specimens 
Only coli in 7 out of 7 
specimens 
Sh.  flezneri  plus  E. 
coli, antiserum 
90-99  per  cent  col 
1-10  per  cent 
Shlgdla  in 5 out of 
7 stool specimens 
Only coli in 7 out of 7 
specimens 
* The specimens not accounted for in this table were sterile. 
terial effect of the immunization on Shigella growing under such competitive 
conditions would have become apparent in the stool cultures. 
DISCUSSION 
The experiments described in the first part of this paper demonstrate that 
bacterial  antagonism  is  a  definite  factor  in  resistance  to  enteric  infection. 
Only one strain of E.  coli  and one strain each of ShigeUa flexneri  and  Vibrio 
cholerae were used in the present studies and no definite conclusions can there- 
fore be drawn as to how common this phenomenon may be. The fact that the 
coli  strain used was originally isolated from a  healthy human being suggests 
however, that at least some individuals might harbor similar strains.  The in 
v/vo antagonistic effect of the coli  strain could be demonstrated equally well 
in  two  different species,  guinea  pigs  and  mice.  This observation adds  some 
weight to the assumption that a  similar protective mechanism might also be 
operative in human beings which carry a suitable normal enteric flora. 
It  is  interesting  to  note  that  no  diffusible  antibiotic  substance  could  be 
demonstrated with either Halbert's (14) or Fredericq's (13) technique in plate 
cultures  of  the  coli  strain  studied.  This  might  possibly  explain  the  lack  of 
correlation between resistance to Shigella infection and the presence of colicine- 
producing bacteria reported by Halbert (3). 
Several possible  explanations  can be advanced  to account for the in  ~ivo 
inhibitory action  of  the  coli  strain  used  in  the  present  studies.  This  strain 418  ENTERIC SHIGELLA AND  VIBRIO INFECTIONS 
might overgrow the Shigdla or Vibrio in the intestine because of the production 
of  an  extremely  unstable  antibiotic  substance,  such  as  that  described  by 
Wynne and Norman (16),  or it might successfully compete for essential nutri- 
ents. A mere difference in growth rate might also account for the effects ob- 
served. 
The lack of antibacterial effect of passive immunization was observed for 
two different microorganisms and in two different kinds of animals. The same 
negative result was obtained in Shigdla infections of actively immunized mice. 
The  evidence presented  does  not  preclude  that  different techniques  might 
reveal some degree of antibacterial effect of immunization such as that found 
by Burrows and his coworkers (8,  9,  17).  It can however be concluded with 
some certainty that any antibacterial effect of immunization in experimental 
enteric infections would be at least far inferior to that of antagonistic normal 
flora. 
SUMMARY 
A  method has  been  devised  for inhibiting  the  normal  enteric  flora,  per- 
mitting long term asymptomafic enteric infections of mice and guinea pigs 
with streptomycin-resistant strains of Shigella flexneri or Vibrio cholerae. 
Introduction of a streptomycin-resistant strain of E. coli into the intestinal 
tract of experimental animals resulted in a  rapid elimination of the  enteric 
pathogens  studied.  No  in  vitro  production  of antibiotic  substances  by  this 
coli strain could be demonstrated. 
Active and oral passive immunization did not noticeably influence the num- 
ber of Shigdla or Vibrio organisms recoverable from the feces of infected animals. 
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